Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» U.S. FDA advisors set to review opioid constipation drugs
U.S. FDA advisors set to review opioid constipation drugs
U.S. FDA advisors set to review opioid constipation drugs
Submitted by
admin
on June 9, 2014 - 11:04am
Source:
Yahoo/Reuters
News Tags:
FDA
opioid-induced constipation
Salix
Relistor
Cubist Pharmaceuticals
Entereg
AstraZeneca
Nektar
Naloxegol
Headline:
U.S. FDA advisors set to review opioid constipation drugs
Do Not Allow Advertisers to Use My Personal information
